Evidence map›Paper›PMID 36560946›Full record

ArticleFrontiers in microbiology2022

Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms.

Antonio Mazzarelli, Maria Letizia Giancola, Andrea Fontana, Pierluca Piselli, Elena Binda, Nadia Trivieri, Gandino Mencarelli, Luisa Marchioni, Antonella Vulcano, Chiara De Giuli and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Human microbiome in post-acute COVID-19 syndrome (PACS).Current research in microbial sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Antonio MazzarelliNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Maria Letizia GiancolaNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Andrea FontanaBiostatistic Unit, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Pierluca PiselliNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Elena BindaCancer Stem Cells Unit, Institute for Stem Cell Biologyl, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
Nadia TrivieriCancer Stem Cells Unit, Institute for Stem Cell Biologyl, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
Gandino MencarelliCancer Stem Cells Unit, Institute for Stem Cell Biologyl, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
Luisa MarchioniNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Antonella VulcanoNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Chiara De GiuliNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Concetta PanebiancoDivision of Gastroenterology, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Annacandida VillaniDivision of Gastroenterology, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Massimiliano CopettiBiostatistic Unit, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Francesco PerriDivision of Gastroenterology, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Carla FontanaNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Emanuele NicastriNational Institute for Infectious Diseases, INMI "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Valerio PazienzaDivision of Gastroenterology, Fondazione-IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITCasa Sollievo della Sofferenza · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersCOVID-19intensive and critical caremicrobiota (16S rRNA)SARS-CoV-2

Identifiers

PMID36560946
PMCPMC9763305
OpenAlexW4311619447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.